Literature DB >> 24866083

Short communication: Prevalence and risk factors for human T cell lymphotropic virus infection in Southern Brazilian HIV-positive patients.

Leonardo Ramos Galetto1, Vagner Ricardo Lunge, Jorge Umberto Béria, Daniela Cardoso Tietzmann, Airton Tetelbom Stein, Daniel Simon.   

Abstract

HIV/human T cell lymphotropic virus (HTLV) coinfection has a large range of prevalence in the different risk groups and geographic regions of the world. Most of the HTLV-infected people live in geographic areas where the virus is endemic, as it happens in Brazil. The aim of this study was to identify HTLV prevalence and risk factors in HIV-positive patients. A cross-sectional study was conducted with 580 HIV-positive patients (mean age of 40.6 years and 45.0% men) from a specialized HIV/AIDS diagnosis and treatment center in Southern Brazil. Sociodemographic data, HIV risk factors, and HTLV-1/2 antibodies were collected. HTLV proviral DNA was detected by polymerase chain reaction (PCR). A multivariate analysis was performed to identify risk factors for HTLV infection. HTLV antibodies were detected in 29 (5.0%) and HTLV provirus in 17 (2.9%) patients. HTLV-1 was identified in 11 (64.7%) patients and HTLV-2 in 6 (35.3%) patients. No significant differences were observed between mono and coinfected patients in clinical characteristics regarding HIV/AIDS (time since HIV diagnosis, HIV viral load, lymphocytes CD4(+) count, and use of highly active antiretroviral therapy). Blood transfusion history was significantly associated with HIV/HTLV coinfection (p=0.039). Alcohol abuse was more prevalent in HTLV-positive (47.1%) than in HIV mono-infected patients (20.4%; p=0.008). Tattooing was the only risk factor independently associated with HIV/HTLV coinfection (p=0.035). This information contributes to an understanding of the epidemiology of HIV/HTLV coinfection in Brazil.

Entities:  

Mesh:

Year:  2014        PMID: 24866083     DOI: 10.1089/AID.2013.0210

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  11 in total

Review 1.  HIV and Substance Use in Latin America: A Scoping Review.

Authors:  Hanalise V Huff; Paloma M Carcamo; Monica M Diaz; Jamie L Conklin; Justina Salvatierra; Rocio Aponte; Patricia J Garcia
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

2.  Molecular Detection and Clinical Implications of HTLV-1 Infections among Antiretroviral Therapy-Naïve HIV-1-Infected Individuals in Abuja, Nigeria.

Authors:  Idris Abdullahi Nasir; Abdurrahman Elfulaty Ahmad; Anthony Uchenna Emeribe; Muhammad Sagir Shehu; Jessy Thomas Medugu; Adamu Babayo
Journal:  Virology (Auckl)       Date:  2015-12-14

Review 3.  HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.

Authors:  Nicolas Futsch; Renaud Mahieux; Hélène Dutartre
Journal:  Viruses       Date:  2017-12-21       Impact factor: 5.048

4.  The first survey of human T-cell lymphotropic viruses (HTLV) in HIV/AIDS patients in Santa Catarina State, Brazil.

Authors:  Chaiana Esmeraldino Mendes Marcon; Karoline Rodrigues Campos; Gabriela Bassi da Silva; Fabiana Schuelter-Trevisol; Aline Daiane Schlindwein; Daisson José Trevisol; Adele Caterino-de-Araujo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-10-10       Impact factor: 1.846

5.  Distribution of Human Immunodeficiency Virus and Human T-Leukemia Virus Co-infection in Bahia, Brazil.

Authors:  Felicidade Mota Pereira; Fred Luciano Neves Santos; Ângelo Antônio Oliveira Silva; Nathan Menezes Nascimento; Maria da Conceição Chagas Almeida; Roberto Perez Carreiro; Bernardo Galvão-Castro; Maria Fernanda Rios Grassi
Journal:  Front Med (Lausanne)       Date:  2022-01-10

Review 6.  HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review.

Authors:  Daniel Bradshaw; Graham Philip Taylor
Journal:  Front Med (Lausanne)       Date:  2022-04-29

7.  Prevalence of infection by human T Cell lymphotropic viruses (HTLV-1/2) in adult population in Vitória-ES.

Authors:  Maria P S Orletti; Tatiane Assone; Glenia Daros Sarnaglia; Marina Lobato Martins; Carolina Rosadas; Jorge Casseb; Graham Taylor; Joaquim B Ferreira-Filho; Fausto E L Pereira; Angélica Espinosa Miranda
Journal:  Braz J Infect Dis       Date:  2021-10-14       Impact factor: 3.257

8.  SEROPREVALENCE OF HTLV IN A POPULATION OF HIV1-INFECTED PATIENTS IN MIDWESTERN BRAZIL.

Authors:  Aline Garcia Kozlowski; Márcia Alves Dias de Matos; Megmar Aparecida Dos Santos Carneiro; Carmen Luci Rodrigues Lopes; Sheila Araújo Teles; Carolina Paulo Vicente; Regina Maria Bringel Martins
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846

9.  Prevalence and Molecular Epidemiology of Human T-Lymphotropic Virus (HTLV) Infection in People Living With HIV/AIDS in the Pará State, Amazon Region of Brazil.

Authors:  Samira Peixoto Alencar; Marlinda de Carvalho Souza; Ricardo Roberto de Souza Fonseca; Cláudia Ribeiro Menezes; Vânia Nakauth Azevedo; Andre Luis Ribeiro Ribeiro; Sandra Souza Lima; Rogério Valois Laurentino; Maria Dos Anjos de Abreu Pina Barbosa; Felipe Bonfim Freitas; Aldemir Branco Oliveira-Filho; Luiz Fernando Almeida Machado
Journal:  Front Microbiol       Date:  2020-10-22       Impact factor: 5.640

10.  Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid and Accurate Confirmatory Diagnosis of HTLV-1/2 Infection.

Authors:  Yago Gomes; Adele Caterino-de-Araujo; Karoline Campos; Maria Gisele Gonçalves; Ana Claudia Leite; Marco Antonio Lima; Abelardo Araújo; Marcus Tulius Silva; Otávio Espíndola
Journal:  Viruses       Date:  2020-09-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.